Zimmer Biomet (ZBH) operating income was $1.1B in FY2025 (-15% YoY). The tables below show the complete quarterly and annual operating income history, sourced from SEC EDGAR 10-K and 10-Q filings.
Annual Operating Income
Fiscal Year
Operating Income
YoY
2025
$1.1B
-15%
2024
$1.3B
+1%
2023
$1.3B
+83%
2022
$696M
-22%
2021
$892M
+974%
2020
$83M
-93%
2019
$1.1B
+3265%
2018
$34M
-96%
2017
$817M
-10%
2016
$912M
+37%
2015
$663M
-36%
2014
$1.0B
-3%
2013
$1.1B
+2%
2012
$1.0B
+2%
2011
$1.0B
+12%
2010
$917M
-10%
2009
$1.0B
-7%
2008
$1.1B
-3%
2007
$1.1B
Recent Quarterly Operating Income
Quarter
Operating Income
Q2 2026
$326M
Q1 2026
$373M
Q4 2025
$154M
Q3 2025
$351M
Q2 2025
$300M
Q1 2025
$292M
Q4 2024
$389M
Q3 2024
$280M
Q2 2024
$351M
Q1 2024
$266M
Q4 2023
$354M
Q3 2023
$267M
Source: ZBH on EDGAR. Data from SEC EDGAR 10-K and 10-Q filings. Updated quarterly.